baber/WOPTO huggingface dataset:
Patent WO-2005002404-A1 (WO)
Title: Centrifugeuse
Inventor: HENSEL KEITH JAMES
IPC: A47J19/02
Filed: 2004-06-24
Abstract: Selon la présente invention, un couvercle (12) d'une centrifugeuse comporte plusieurs fonctions importantes. Il empêche, notamment, le jus de s'échapper, il dévie la pulpe efficacement vers un collecteur (13) ou une chute (150), il coopère avec une barre de verrouillage afin de maintenir le dispositif à un état fixe et fermé, et il constitue une plate-forme destinée au tube d'alimentation. Ledit couvercle (12) comporte un capuchon polymère (52) (par exemple, un polycarbonate), auquel est attaché un tube d'alimentation métallique, de préférence, en acier inoxydable (51). La combinaison d'un capuchon transparent (52) et d'un tube d'alimentation en acier engendre tous les avantages des deux éléments, à savoir, une résistance adéquate dans le tube d'alimentation et le couteau et la possibilité de voir sous le capuchon.
Patent AU-2004204720-A1 (AU)
Title: Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant
Inventor: CHEN BAO-LU
IPC: A61K38/00
Filed: 2004-01-08
Abstract: Stabilized aqueous compositions of tissue factor pathway inhibitor (TFPI) or TFPI variants comprise a solubilizing agent, an antioxidant, and a buffer. The combination of a solubilizing agent and an antioxidant can lead to a significant improvement in the storage life of TFPI or TFPI variant compositions. The solubilizing agent and antioxidant substantially counteract the effects of TFPI or TFPI variant degradation through aggregation and oxidation.
Patent AU-2004265232-A1 (AU)
Title: Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens
Inventor: BHARGAVA SANGEETA
IPC: C07K14/115
Filed: 2004-06-02
Abstract: Self-propagating, fusogenic blebs are produced from cells infected with a population of Venezuelan Equine Encephalitis virus replicon particles (VRP). The self-propagating, fusogenic nature of the blebs is derived from expression of heterologous genes encoding viral fusion proteins that are incorporated into the replication defective replicon particles. The resulting blebs can be harvested from supernatants of cells displaying severe cytopathic effects. The blebs are used to make immunogenic compositions and devise methods of immunizing mammals against paramyxoviruses such as parainfluenza virus type 3.
Patent AU-2004295684-A1 (AU)
Title: Fiber optic device for sensing analytes
Inventor: ALARCON JAVIER
IPC: G01N33/543
Filed: 2004-11-12
Abstract: A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. An optical conduit, preferably an optical fiber has an optical system at the proximal end of the optical conduit. A sensing element is attached to the distal end of the optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the sensing element includes reference groups with luminescence properties that are substantially unchanged by variations in the analyte concentrations.
Patent AU-2004305625-A1 (AU)
Title: Grid stabilising system
Inventor: HIRST DAVID
IPC: H02J3/14
Filed: 2004-09-22
Abstract: The invention provides control of an electric load receiving power from a grid. The frequency of the grid is detected and used to determine a stress level on the grid. A high frequency detection is indicative of too little a load for the electrical power being supplied to the grid and, therefore, a low stress condition. A high stress condition may exist if there is too much load for the power being supplied to the grid. Adjustment of the power consumption of the load is prevented if the high and/or low stress states is determined. If a critical high or low stress condition is determined, the load is either prevented from consuming power completely or the load is set to a maximum power consumption state, respectively. The benefits of the invention are increased if the device is combined with a load controller which operates to control power consumption based on grid frequency and a variable, which, for the particular load, is to be kept within controlled limits.
Patent WO-2006032086-A1 (WO)
Title: Dérivés de chromane, médicaments et utilisation à des fins thérapeutiques
Inventor: HEATON ANDREW
IPC: C07D311/38
Filed: 2005-09-21
Abstract: La présente invention décrit de nouveaux dérivés de chromane et des composés intermédiaires, des compositions les comprenant, des procédés pour leur préparation et l’utilisation de ceux-ci comme agents thérapeutiques, particulièrement comme agents sélectifs anticancéreux et chimiothérapeutiques.
Patent AU-2005209336-A1 (AU)
Title: Method for the manufacture of carboxyalkylinulin
Inventor: RAAIJMAKERS HARRY W C
IPC: C08B37/00
Filed: 2005-01-28
Abstract: A method for the manufacture of carboxyalkylinulin is disclosed comprising preparing an aqueous medium containing dispersed therein a halogenoalkylcarboxylate, adding to the carboxylate containing medium, under substantially neutral pH conditions, an inulin followed by heating this mixture to a temperature in the range of from 60  DEG C to 90  DEG C and proceeding with the reaction at alkaline conditions, pH 8-12, while simultaneously adding additional halogenoalkylcarboxylate and alkalihydroxide. The carboxyalkylinulin so formed is recovered in a manner known per se.
Patent AU-2005214970-A1 (AU)
Title: Methods and materials using signaling probes
Inventor: MONTEZ JASON M
IPC: C12N15/00
Filed: 2005-02-17
Abstract: The present invention relates to methods of isolating cells or generating cell lines using signaling probes that produce a signal upon hybridization to a target sequence. Other methods that utilize the signaling probe include methods of quantifying the level of RNA expression, methods for identifying genetic recombinational events in living cells and methods of generating a transgenic animal using the isolated cells. The invention also provides protease probes. Signaling probes and protease probes that form stem-loop structures, three-arm junction structures, and dumbbell structures are provided.
Patent AU-2005234728-A1 (AU)
Title: Device for forming groups of products, for instance for automatic packaging machinery
Inventor: GUIDETTI DARIO
IPC: B65B35/16
Filed: 2005-11-21
Abstract: A device for forming groups of products, comprising:  a stationary base structure (12),  a support (14), movable relative to the base structure (12), and  a plurality of grip units (18) borne by the movable support (14), the grip units (18) being movable from a position (26) for receiving products (P), to a position (28) for releasing the groups of products (G), and being capable of receiving the products (P) advancing along a given direction (22) in the position of receipt (26) and of forming groups of products (G) comprising a predetermined number of products.    The grip units (18) can be selectively disassembled and re-assembled relative to the movable support (14) independently from each other.
Patent AU-2005235176-A1 (AU)
Title: Slow closing mechanism for toilet covers
Inventor: ER OSMAN
IPC: A47K13/12
Filed: 2005-04-08
Abstract: Slow closing mechanism (A) for toilet covers according to the invention comprises left hinge shaft ( 1 ), right hinge shaft ( 2 ), main frame ( 3 ) and toilet fitting legs with slots ( 4 ) on the main frame ( 3 ), damper housings ( 5 ), compressing member ( 6 ) and slow closing dampers ( 7 ) and enabling easy fitting and disassembly on existing toilet covers without any modification.
Patent AU-2005244438-A1 (AU)
Title: Optical sensor for in vivo detection of analyte
Inventor: KRISTENSEN JESPER SVENNING
IPC: A61K49/00
Filed: 2005-05-17
Abstract: A sensor for the in vivo detection of glucose comprises: components of an assay for glucose, a readout of which is a detectable optical signal which can be interrogated transcutaneously by external optical means when the sensor is implanted in vivo; and a shell of biodegradable material encapsulating the assay components while allowing analyte to contact the assay components, wherein the biodegradable material comprises a co-polymer having hydrophobic and hydrophilic units. A method of preparing such a sensor preferably comprises coacervation, solvent evaporation and/or extraction, spray drying, spray coating, spray chilling, rotary disk atomisation, fluid bed coating, coextrusion and/or pan coating. A method of detecting glucose using such a sensor suitably comprises implantation of the sensor into the skin of a mammal, transdermal detection or measurement of glucose using external optical means and degradation of the biodegradable material.
Patent AU-2005271113-A1 (AU)
Title: Methods and kit for the prognosis of breast cancer
Inventor: JIANG WEN GUO
IPC: C12Q1/68
Filed: 2005-07-27
Abstract: The present invention relates to a method and kit, including parts thereof, for the prognosis of breast cancer. In particular, the method involves identifying a gene expression pattern, or molecular signature, that indicates the likelihood of survival of a patient with breast cancer, and/or likelihood of recurrence of the disease in a patient being treated, or having been treated, for breast cancer, and the likelihood of a patient having a metastatic form of cancer. Six molecular signatures, comprising twelve groups/sets of molecular markers have been identified, which have relevance in determining the prognosis of a given breast cancer. Each molecular signature comprises a plurality of genetic markers whose expression, either high or low in respect of normal tissue, is indicative of a given outcome, such as survival or recurrence.
Patent WO-2006092010-A1 (WO)
Title: Lance extraction
Inventor: GOODMAN NEIL JOHN
IPC: F27D3/16
Filed: 2006-03-01
Abstract: Solids injection lances (27a, 27b) for injecting solids into a metallurgical vessel are normally supplied with cooling water from a cooling water circuit through water supply lines (71) and return lines (72). Supply lines (71) are provided with spaced pairs of connectors (80) and bypass valves (73), and return lines (72) are provided with similar pairs of spaced connectors (81) and bypass valves (74). Flexible hoses (75, 76) can be connected between the pairs of connectors (80, 81) to establish supply and return flows of cooling water which bypass segments of the main supply and return lines (71, 72) which can be isolated and removed to allow withdrawal and subsequent replacement of the lances.
Patent WO-2006116804-A1 (WO)
Title: Agent de la graine de hyoscyamus traitee pour le traitement de rupture de tissus
Inventor: JOO GOH CHIN
IPC: A61K36/81
Filed: 2006-04-28
Abstract: La présente invention concerne un agent pour le traitement d'une rupture de tissus et permet d'obtenir une composition qui comprend une graine d'Hyoscyamus traitée, ainsi que des méthodes d'utilisation d'une graine d'Hyoscyamus traitée.
Patent AU-2006200284-A1 (AU)
Title: Surgical stapling instrument incorporating a multi-stroke firing mechanism with return spring rotary manual retraction system
Inventor: IV FREDRICK E SHELTON
IPC: A61B17/068
Filed: 2006-01-23
Abstract: A surgical stapling and severing instrument particularly suited to endoscopic procedures incorporates a handle that produces separate closing and firing motions to actuate an end effector. In particular, the handle produces multiple firing strokes in order to reduce the required amount of force required to fire (i.e., staple and sever) the end effector. A linked transmission reduces the required handle longitudinal length, yet achieves a rigid, strong configuration when straightened for firing. A traction biased firing mechanism avoids binding in driving this straightened linked rack in cooperation with an anti-backup mechanism, with a lockout mechanism that prevents releasing the closure trigger during firing. Furthermore, an external indicator gives feedback to the surgeon as to how far firing has progressed, as well as providing a manual retraction capability.
Patent AU-2006203021-A1 (AU)
Title: Apparatus for single pass gastric restriction
Inventor: ORTIZ MARK S
IPC: A61B17/00
Filed: 2006-07-14
Abstract: A gastric reduction apparatus that facilitates the creation of a transoral linear passageway through the stomach includes an elongated body including a proximal end and a distal end. The elongated body is generally sinusoidal shaped with at least one tissue engaging surface oriented such that a needle will pass therethrough. The elongated body also includes at least one needle passing channel respectively formed adjacent the at least one tissue engaging surface. The at least one needle passing channel generally passes through the center of the sinusoidal waveforms defined by the at least one tissue engaging surface such that a needle will pass entirely through stomach tissue contacting the tissue engaging surface of the elongated body. The elongated body further includes a suture passing channel.
Patent AU-2006215246-A1 (AU)
Title: Valved fenestrated tracheotomy tube having outer and inner cannulae
Inventor: BLOM ERIC D
IPC: A61M16/04
Filed: 2006-09-14
Abstract: A tracheotomy tube apparatus (10) includes an outer cannula (12) having a fenestration (56) and an inflatable cuff (16) formed by a sleeve (42), a first inner cannula (60) having a raised region (64) substantially to close the fenestration when the first inner cannula is inserted into the outer cannula, and a second inner cannula (80) for insertion into the outer cannula when the first inner cannula is removed therefrom. The second inner cannula includes a resilient region (82) which lies adjacent the fenestration when the second inner cannula is properly oriented within the outer cannula, a valve (88) at an end thereof and a region (86) between the resilient region and the end thereof which provides a passageway (87) between the second inner cannula and the outer cannula when the second inner cannula is properly oriented within the outer cannula. The first inner cannula includes a conduit (70) to evacuate a region of a trachea (18) of a wearer adjacent the cuff. The conduit includes an opening (72) which lies adjacent the closest point in the fenestration to the cuff when the first inner cannula is in a use orientation in the outer cannula.
Patent AU-2006229740-A1 (AU)
Title: FCC process combining molecular separation with staged conversion
Inventor: LOWENTHAL STEVEN S
IPC: B01D61/00
Filed: 2006-03-10
Abstract: This invention relates to fluid catalytic cracking (FCC) process for improving the quality of distillates suitable as blend stocks for diesel fuels. The FCC process combines staging the FCC conversion process with interstage molecular separation of multi-ring aromatic species. Lower and higher severity reaction zones in the riser of the FCC reactor are combined with selective molecular separations to improve the production of diesel quality distillates.
Patent AU-2006284940-A1 (AU)
Title: Therapy for the treatment of disease
Inventor: PABORJI MEHDI
IPC: A61K31/137
Filed: 2006-08-28
Abstract: Disclosed herein are pharmaceutical compositions comprising oxybutynin or tolterodine, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.
Patent WO-2008014546-A1 (WO)
Title: Dispositif de coup à lames
Inventor: RAYNER WILLIAM
IPC: B26D1/15
Filed: 2007-07-31
Abstract: L'invention concerne un dispositif manuel de coupe à lames qui permet de couper un matériau en feuille souple, le dispositif de coupe comportant un corps de coupe qui est mobile sur une surface de travail sur laquelle la feuille souple devant être coupée peut reposer. Le dispositif comporte un ensemble lame de coupe monté de manière fonctionnelle sur le corps de coupe et comprenant une lame de coupe rotative ayant une partie bord périphérique et une lame de coupe fixe adaptées pour coopérer afin de créer une zone de coupe dans laquelle le matériau en feuille peut être coupé. La lame de coupe rotative est montée de manière à tourner autour d'un axe qui s'étend généralement de manière latérale par rapport à une direction d'arrivée normale du matériau en feuille jusqu'à la zone de coupe et la direction de rotation de la partie bord périphérique dans de la zone de coupe se situe dans la direction d'arrivée normale. La vitesse périphérique tangentielle de la lame de coupe rotative dans la zone de coupe n'est pas inférieure à la vitesse d'arrivée du matériau en feuille jusqu'à la zone de coupe.
Patent AU-2007293673-A1 (AU)
Title: Vaccine
Inventor: MARY ANNE
IPC: A61K39/00
Filed: 2007-09-07
Abstract: The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio.
Patent AU-2007339189-A1 (AU)
Title: Cosmetic
Inventor: KAKOKI HIROYUKI
IPC: A61Q5/06
Filed: 2007-12-26
Abstract: The present invention provides a cosmetic having equal to or a higher antioxidantactivity and moisture retaining property than the above-described conventional vitamin E derivatives. The cosmetic also has an excellent emulsifying ability and solubilizing ability and remarkably reduces a sticky feeling on the skin (in particular, the sticky feeling during drying after the application on the skin).  That is, the cosmetic of the present invention containinga vitamin E derivative represented by the following formula (I) or a salt thereof.   
[ In the formula, R 1 , R 2  , and R 3  represent a hydrogen atom or a methyl group; R 4  represents a C 1-6  alkanoyl group, a C 1-6  alkyl group, a SO 3 H group, a P(O)(OH) 2  group, a CH 2 COOH group or a COCH 2 CH(SO 3 H)COOH group; EO represents an ethylene oxide group; BO represents a butylene oxide group; k and n independently represent any one of numbers 0 to 30; and m represents any one of numbers 1 to 30.]
Patent AU-2008231824-A1 (AU)
Title: Lifting gear
Inventor: BACKSMANN JURGEN
IPC: B66D1/16
Filed: 2008-03-18
Abstract: The invention relates to lifting gear having a drive unit (2), a drive shaft (3), which has a drive flange (4) fixable thereon and can be driven by the drive unit (2), and a cable drum (5) that can be connected to the drive flange by means of a coupling, said coupling comprising at least one coupling element (10) engaging in a recess (11) in the drive flange (4) and in a hole (12) in the cable drum (5) to transmit torque. In order to equip a lifting gear having a drive unit comprising a motor and a gearbox with a coupling, which ensures simple assembly with a simple and space-saving design, according to the invention the coupling element (10) is movable and fixable radially from an assembly position into an operating position, in which the coupling element (10) connects the drive flange (4) to the cable drum (5) in a driveable manner.
Patent AU-2009217420-A1 (AU)
Title: Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
Inventor: SHEVCHUK IHOR
IPC: A61K9/70
Filed: 2009-09-18
Abstract: The present invention relates to a transdermal delivery device disposal system for disposing of a transdermal delivery device containing at least one pharmaceutically active component. The disposal system contains at least one sheet or substrate on which an adhesive is coated; and one or more of the following components: (a) monomer, and optionally comonomer(s), to be polymerized; (b) an initiator, and optionally co-initiator(s), to initiate the polymerization; (c) at least one crosslinking agent to crosslink the (co)polymer; and (d) at least one deactivating agent to chemically alter, to degrade, and/or to deactivate the active component(s) contained in the transdermal delivery device, such as an opioid antagonist or an opioid agonist deactivating agent so that the euphoric effects of the active component(s) contained in the transdermal delivery device are at least temporarily inhibited, diminished, or halted  in vivo , wherein at least one adhesive-coated sheet or substrate adheres to, immobilizes, or isolates, and prevents, inhibits, or diminishes the misuse or abuse of the active component contained in, at least one transdermal delivery device.
Patent AU-2009323868-A1 (AU)
Title: Apparatus and method for servicing a wellbore
Inventor: ROBERT HOWARD
IPC: E21B43/119
Filed: 2009-12-02
Abstract: A wellbore servicing apparatus (100), comprising a first mandrel (252) movable longitudinally along a central axis and rotatable about the central axis, an orienting member (244) configured to selectively interfere with movement of the first mandrel along the central axis, and a second mandrel (146) connected to the first mandrel and configured to rotate about the central axis when the first mandrel rotates about the central axis. A method of orienting a wellbore servicing tool, comprising connecting an orienting tool to the wellbore servicing tool, identifying a predetermined direction, increasing a pressure within the orienting tool, rotating a portion of the orienting tool in response to the increase in pressure within the orienting tool, and rotating the wellbore servicing tool in response to the rotating of the portion of the orienting tool.
Patent AU-2009329084-A1 (AU)
Title: A novel dermaceutical cream made using Sodium Fusidate
Inventor: SUBRAMANIAM VANANGAMUDI SULUR
IPC: A61K9/06
Filed: 2009-12-16
Abstract: The present invention relates to primary and secondary bacterial skin infections and in particular it relates to the treatment of these infections using a Fusidic acid cream that has been made using Sodium fusidate as the starting Active Pharmaceutical Ingredient (API). The invention discloses a dermaceutical cream containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment. The cream of the present invention has greater shelf-life stability and the finer particle size of the API than the conventional creams containing Fusidic acid.
Patent AU-2009346357-A1 (AU)
Title: Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
Inventor: ANDREW NOWAK
IPC: A61K31/785
Filed: 2009-05-18
Abstract: The invention describes the modification of polyamine-based materials to form polyguanidine compounds that are useful for their antimicrobial, anticaries, and muccoadhesive properties. The present invention also relates to methods for preventing or treating periodontal disease and caries which include delivering a therapeutically effective amount of an oral composition containing a polyguanidine compound into an oral cavity.